Literature DB >> 15938168

Induced abortion in Thailand: current situation in public hospitals and legal perspectives.

Suwanna Warakamin1, Nongluk Boonthai, Viroj Tangcharoensathien.   

Abstract

Abortion is illegal in Thailand unless the woman's health is at risk or pregnancy is due to rape. This study, carried out in 1999 in 787 government hospitals, examined the magnitude and profile of abortion in Thailand, using data collected prospectively through a review of 45,990 case records (of which 28.5% were classified as induced and 71.5% as spontaneous abortions) and face-to-face interviews with a sub-set of 1854 women patients. The estimated induced abortion ratio was 19.5 per 1000 live births. Almost half the induced abortions were in young women under 25 years of age, many of whom had little or no access to contraception. Socio-economic reasons accounted for 60.2% of abortions. Serious complications were observed in almost a third of cases, especially following abortions performed by non-health personnel. Government physicians' current provision of induced abortion went beyond the provisions of the law in almost half of cases, most commonly for intrauterine death and for congenital anomalies. The paper proposes a framework for policy discussions of the grey areas of maternal and fetal indications leading to legal reform, in order to facilitate safe abortion. A recommendation to amend the abortion law has been proposed to the Ministry of Public Health and the Thai Medical Council.

Entities:  

Mesh:

Year:  2004        PMID: 15938168     DOI: 10.1016/s0968-8080(04)24018-6

Source DB:  PubMed          Journal:  Reprod Health Matters        ISSN: 0968-8080


  7 in total

1.  Cause-specific mortality patterns among hospital deaths in Thailand: validating routine death certification.

Authors:  Junya Pattaraarchachai; Chalapati Rao; Warangkana Polprasert; Yawarat Porapakkham; Wansa Pao-In; Noppcha Singwerathum; Alan D Lopez
Journal:  Popul Health Metr       Date:  2010-05-18

2.  Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand.

Authors:  Punnee Pitisuttithum; Supachai Rerks-Ngarm; Valai Bussaratid; Jittima Dhitavat; Wirach Maekanantawat; Swangjai Pungpak; Pravan Suntharasamai; Sirivan Vanijanonta; Sorachai Nitayapan; Jaranit Kaewkungwal; Michael Benenson; Patricia Morgan; Robert J O'Connell; Jeffrey Berenberg; Sanjay Gurunathan; Donald P Francis; Robert Paris; Joseph Chiu; Donald Stablein; Nelson L Michael; Jean-Louis Excler; Merlin L Robb; Jerome H Kim
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

3.  A survey of manual vacuum aspiration's experiences among the new medical graduates in Thailand.

Authors:  Rapeepong Suphanchaimat; Nongluk Boonthai; Sasikan Tangthasana; Weerasak Putthasri; Viroj Tangcharoensathien; Kamheang Chaturachinda
Journal:  Reprod Health       Date:  2013-09-11       Impact factor: 3.223

4.  To be, or not to be, referred: A qualitative study of women from Burma's access to legal abortion care in Thailand.

Authors:  Grady Arnott; Eh Tho; Niru Guroong; Angel M Foster
Journal:  PLoS One       Date:  2017-06-12       Impact factor: 3.240

5.  Exploring Legal Restrictions, Regulatory Reform, and Geographic Disparities in Abortion Access in Thailand.

Authors:  Grady Arnott; Grace Sheehy; Orawee Chinthakanan; Angel M Foster
Journal:  Health Hum Rights       Date:  2017-06

6.  A commentary on the recent ruling by the Thai Constitutional Court in relation to abortion law in Thailand.

Authors:  K Chaturachinda; N Boonthai
Journal:  Sex Reprod Health Matters       Date:  2020-12

7.  Healthcare Providers' Knowledge and Attitude Towards Abortions in Thailand: A Pre-Post Evaluation of Trainings on Safe Abortion.

Authors:  Rugsapon Sanitya; Aniqa Islam Marshall; Nithiwat Saengruang; Sataporn Julchoo; Pigunkaew Sinam; Rapeepong Suphanchaimat; Mathudara Phaiyarom; Viroj Tangcharoensathien; Nongluk Boonthai; Kamheang Chaturachinda
Journal:  Int J Environ Res Public Health       Date:  2020-05-04       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.